PROM1 and non-small cell lung carcinoma: Compared with LC-CD133−, LC-CD133+ derived from NSCLC Patients No.1 (PLC) and No. 2 (LLC) showed higher invasion activity through Matrigel Transwell invasion assay (p<0.001; Fig. 2C).